* Adapthealth Corp AHCO.OQ AHCO.O is expected to show a
rise
in quarterly revenue when it reports results on August 8.
* The Plymouth Meeting Pennsylvania-based company is
expected to
report a 5.2% increase in revenue to $765.204 million from
$727.61 million a year ago, according to the mean estimate from
10 analysts, based on Refinitiv data. The company's guidance on
May 9 2023, for the period ended June 30, was for revenue
between $756.72 million and $771.27 million.
* Refinitiv's mean analyst estimate for Adapthealth Corp is
for
earnings of 10 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Adapthealth
Corp
is $15.5, above its last closing price of $13.43.
The company's guidance on May 9 2023 for the period ended June
30 was for Earnings before Interest, Taxes, Depreciation and
Amortization of between USD756.71856 million and USD154.25417
million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.08 0.08 0.11 Beat 42.6
Dec. 31 2023 0.25 0.28 -0.02 Missed -107
Sep. 30 2022 0.31 0.31 0.11 Missed -64.7
Jun. 30 2022 0.25 0.26 0.09 Missed -65
Mar. 0.19 0.18 0.08 Missed -55.6
31 2022
Dec. 31 2021 0.32 0.34 0.17 Missed -50.8
Sep. 30 2021 0.27 0.28 0.20 Missed -28.6
Jun. 30 2021 0.20 0.21 0.12 Missed -43.7
This summary was machine generated August 4 at 18:35 GMT. All
figures in US dollars unless otherwise stated